Rossmore Private Capital’s iShares Biotechnology ETF IBB Stock Holding History

Rossmore Private Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Hold	599	–	–	0.01%	318
2026 Q1	$101K	Hold	599	–	–	0.01%	304
2025 Q4	$101K	Hold	599	–	–	0.01%	304
2025 Q3	$86.5K	Buy	+599	New	+$81.8K	0.01%	279
2022 Q1	–	Sell	-1,851	Closed	-$282K	–	226
2021 Q4	$282K	Hold	1,851	–	–	0.04%	196
2021 Q3	$299K	Hold	1,851	–	–	0.05%	194
2021 Q2	$303K	Hold	1,851	–	–	0.05%	187
2021 Q1	$279K	Hold	1,851	–	–	0.05%	184
2020 Q4	$280K	Buy	1,851 +177	+11%	+$25.3K	0.06%	176
2020 Q3	$227K	Hold	1,674	–	–	0.05%	177
2020 Q2	$229K	Buy	+1,674	New	+$213K	0.06%	159
2020 Q1	–	Sell	-1,674	Closed	-$202K	–	156
2019 Q4	$202K	Buy	+1,674	New	+$187K	0.06%	133
2018 Q1	–	Sell	-1,500	Closed	-$160K	–	241
2017 Q4	$160K	Buy	+1,500	New	+$160K	0.16%	100

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Rossmore Private Capital's IBB Position: Q2 2026 in Review

Rossmore Private Capital held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 599 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #318.

Rossmore Private Capital first reported a position in IBB in Q4 2017 and has held it in 13 quarters since. The position peaked at $303K in Q2 2021. 451 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Rossmore Private Capital held 599 shares of iShares Biotechnology ETF worth $114K as of Q2 2026.
Rossmore Private Capital left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Rossmore Private Capital's portfolio in Q2 2026, its #318 holding.
Rossmore Private Capital first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 13 quarters since.
Rossmore Private Capital's iShares Biotechnology ETF position peaked at $303K in Q2 2021.
451 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.